Aave Surges 3.26% on V4 Adoption, DeFi Lending Growth

Tether Gold deposits in DeFi reached $102.9M, with Aave accounting for 74.2% of the total. The growth highlights increasing interest in digital assets and secure DeFi platforms. Tether and Aave are key players in this trend, which may impact market liquidity and investor sentiment.

U.S. stocks had a mixed week, with crypto-linked equities rallying despite legislative setbacks, while Bank of America warned of weaker investment banking outlook. Generac surged on a $2.4B Amazon deal, Tempus AI rose post-conference, and J.B. Hunt fell after an earnings warning. Bitcoin gained 5.5%.

XRP rose 6% in 24 hours, reaching $1.40, as whale inflows to Binance hit a 6-month high of 1.6 billion XRP. The surge follows a selloff after the Clarity Act's failure. Evernorth raised $30 million for spot XRP investments, pending a SPAC merger and Nasdaq listing under XRPN.

Wells Fargo downgraded Netflix to 'underweight', citing weak engagement and content concerns. The firm cut its price target to $57, down 25% from current levels, and lowered its valuation multiple. Netflix shares fell 4% on the news. Analysts pointed to declining viewership and reduced share of U.S. television viewing as key concerns.

Enphase Energy (ENPH) fell 5% to $34.29, while First Solar (FSLR) and Sunrun (RUN) each dropped 4%, driven by broader solar sector weakness. The decline follows a Fed rate hike, which impacts residential solar demand due to financing costs. The Invesco Solar ETF (TAN) also fell 2%, while the S&P 500 ETF (SPY) declined 0.2%.

Xenon Pharmaceuticals (XENE) halted enrollment in a depression study due to adverse events, causing its stock to drop 29% to $40.60. The company submitted a new drug application for its epilepsy treatment, azetukalner, which showed promising results in reducing seizures. Analysts cut price targets but remain optimistic about the epilepsy drug's potential.